PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 16053731-5 2005 RESULTS: IVIG inhibited the PHA-induced proliferation of CBMCs as reflected by the decreased expression of CD25 and CD45RO. cbmcs 57-62 interleukin 2 receptor subunit alpha Homo sapiens 107-111 18442800-7 2008 Interestingly, CD3+CD56+ NKT-like cells from IL-15-cocultured CBMCs had significantly lower apoptotic frequency and higher levels of activation markers (CD161, CD25, and IFN-gamma) than those from IL-2-cocultured CBMCs. cbmcs 62-67 interleukin 2 receptor subunit alpha Homo sapiens 160-164 16053731-11 2005 But a decreased response in CD25(+) CBMCs (77.29% +/- 0.63%, 51.48% +/- 1.85% and 62.73% +/- 1.24%) and CD4(+)CD45RO(+) CD3(+) T lymphocytes (35.47% +/- 2.55%, 40.14% +/- 1.16% and 36.41% +/- 2.96%) was observed when IVIG was added in IVIG pre-inhibition group, PHA pre-activation group and PHA+IVIG group, and the degree of inhibition of IVIG on cord blood CD3(+) T lymphocytes was much lower than that of CBMCs. cbmcs 36-41 interleukin 2 receptor subunit alpha Homo sapiens 28-32 16053731-12 2005 CONCLUSIONS: Cord blood T lymphocytes activation was inhibited by IVIG through the inhibition of CD25(+) CBMCs expression and the prevention of transformation from CD4(+)CD45RA(+) cells into CD4(+)CD45RO(+) cells. cbmcs 105-110 interleukin 2 receptor subunit alpha Homo sapiens 97-101